GLEEVEC 400 MG TABLET

imatinib mesylate
$328.0340per EA
High Outlier

Strength

400 mg/1

NDC

00078064930

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Last Updated

9/18/2024

Active Ingredients

IMATINIB MESYLATE

Approval Type

New Drug (NDA)

FDA Application

NDA021588

On Market Since

12/23/2014

Pharmacological Classes

Bcr-Abl Tyrosine Kinase Inhibitors
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A4 Inhibitors
Kinase Inhibitor

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

-0.1%

5Y

-0.1%

All

+9.6%